vs

Side-by-side financial comparison of AGENUS INC (AGEN) and Canaan Inc. (CAN). Click either name above to swap in a different company.

AGENUS INC is the larger business by last-quarter revenue ($34.2M vs $20.8M, roughly 1.6× Canaan Inc.). Canaan Inc. runs the higher net margin — -18.4% vs -31.0%, a 12.6% gap on every dollar of revenue.

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.

Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.

AGEN vs CAN — Head-to-Head

Bigger by revenue
AGEN
AGEN
1.6× larger
AGEN
$34.2M
$20.8M
CAN
Higher net margin
CAN
CAN
12.6% more per $
CAN
-18.4%
-31.0%
AGEN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AGEN
AGEN
CAN
CAN
Revenue
$34.2M
$20.8M
Net Profit
$-10.6M
$-3.8M
Gross Margin
99.9%
Operating Margin
42.1%
-15.9%
Net Margin
-31.0%
-18.4%
Revenue YoY
27.5%
Net Profit YoY
77.3%
EPS (diluted)
$0.09
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGEN
AGEN
CAN
CAN
Q4 25
$34.2M
$20.8M
Q3 25
$30.2M
$13.8M
Q2 25
$25.7M
$11.4M
Q1 25
$24.1M
Q4 24
$26.8M
Q3 24
$25.1M
$10.2M
Q2 24
$23.5M
$4.8M
Q1 24
$28.0M
Net Profit
AGEN
AGEN
CAN
CAN
Q4 25
$-10.6M
$-3.8M
Q3 25
$63.9M
$-1.5M
Q2 25
$-30.0M
$-11.9M
Q1 25
$-26.4M
Q4 24
$-46.8M
Q3 24
$-67.2M
$-10.4M
Q2 24
$-54.8M
$-5.4M
Q1 24
$-63.5M
Gross Margin
AGEN
AGEN
CAN
CAN
Q4 25
99.9%
Q3 25
97.9%
99.9%
Q2 25
99.1%
99.9%
Q1 25
99.4%
Q4 24
99.6%
Q3 24
99.4%
99.9%
Q2 24
99.5%
99.8%
Q1 24
99.6%
Operating Margin
AGEN
AGEN
CAN
CAN
Q4 25
42.1%
-15.9%
Q3 25
-15.0%
-27.0%
Q2 25
-65.0%
-45.5%
Q1 25
-55.3%
Q4 24
-96.5%
Q3 24
-125.5%
-77.2%
Q2 24
-128.4%
-193.9%
Q1 24
-117.4%
Net Margin
AGEN
AGEN
CAN
CAN
Q4 25
-31.0%
-18.4%
Q3 25
211.4%
-11.0%
Q2 25
-116.8%
-104.4%
Q1 25
-109.6%
Q4 24
-174.4%
Q3 24
-267.7%
-102.7%
Q2 24
-233.1%
-112.3%
Q1 24
-226.6%
EPS (diluted)
AGEN
AGEN
CAN
CAN
Q4 25
$0.09
$-0.05
Q3 25
$1.94
$-0.02
Q2 25
$-1.00
$-0.25
Q1 25
$-1.03
Q4 24
$-1.95
Q3 24
$-3.08
Q2 24
$-2.52
Q1 24
$-3.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGEN
AGEN
CAN
CAN
Cash + ST InvestmentsLiquidity on hand
$3.0M
Total DebtLower is stronger
$44.7M
$6.2M
Stockholders' EquityBook value
$-271.1M
$52.4M
Total Assets
$226.8M
$92.5M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGEN
AGEN
CAN
CAN
Q4 25
$3.0M
Q3 25
$3.5M
Q2 25
$9.5M
Q1 25
$18.5M
Q4 24
$40.4M
Q3 24
$44.8M
Q2 24
$93.7M
Q1 24
$52.9M
Total Debt
AGEN
AGEN
CAN
CAN
Q4 25
$44.7M
$6.2M
Q3 25
$34.2M
$6.2M
Q2 25
$33.9M
$6.2M
Q1 25
$33.6M
Q4 24
$33.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AGEN
AGEN
CAN
CAN
Q4 25
$-271.1M
$52.4M
Q3 25
$-274.1M
$44.7M
Q2 25
$-354.6M
$33.8M
Q1 25
$-341.8M
Q4 24
$-326.4M
Q3 24
$-292.3M
$43.6M
Q2 24
$-241.3M
$56.8M
Q1 24
$-201.4M
Total Assets
AGEN
AGEN
CAN
CAN
Q4 25
$226.8M
$92.5M
Q3 25
$233.9M
$81.7M
Q2 25
$185.2M
$78.0M
Q1 25
$200.2M
Q4 24
$226.3M
Q3 24
$238.5M
$69.3M
Q2 24
$292.4M
$73.7M
Q1 24
$256.6M
Debt / Equity
AGEN
AGEN
CAN
CAN
Q4 25
0.12×
Q3 25
0.14×
Q2 25
0.18×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGEN
AGEN
CAN
CAN
Operating Cash FlowLast quarter
$-16.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGEN
AGEN
CAN
CAN
Q4 25
$-16.6M
Q3 25
$-14.7M
Q2 25
$-20.2M
Q1 25
$-25.6M
Q4 24
$-28.7M
Q3 24
$-53.3M
Q2 24
$-38.2M
Q1 24
$-38.2M
Free Cash Flow
AGEN
AGEN
CAN
CAN
Q4 25
Q3 25
Q2 25
$-20.2M
Q1 25
$-25.6M
Q4 24
$-28.7M
Q3 24
$-53.3M
Q2 24
$-38.6M
Q1 24
$-38.2M
FCF Margin
AGEN
AGEN
CAN
CAN
Q4 25
Q3 25
Q2 25
-78.7%
Q1 25
-106.5%
Q4 24
-107.0%
Q3 24
-212.2%
Q2 24
-164.4%
Q1 24
-136.5%
Capex Intensity
AGEN
AGEN
CAN
CAN
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.3%
Q3 24
0.0%
Q2 24
2.0%
Q1 24
0.1%
Cash Conversion
AGEN
AGEN
CAN
CAN
Q4 25
Q3 25
-0.23×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGEN
AGEN

Non Cash Royalty Revenue$31.1M91%
Other$3.2M9%

CAN
CAN

Segment breakdown not available.

Related Comparisons